Global Metabotropic Glutamate Receptor 5 Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Metabotropic Glutamate Receptor 5 will have significant change from previous year. According to our (LP Information) latest study, the global Metabotropic Glutamate Receptor 5 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Metabotropic Glutamate Receptor 5 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Metabotropic Glutamate Receptor 5 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Metabotropic Glutamate Receptor 5 market, reaching US$ million by the year 2028. As for the Europe Metabotropic Glutamate Receptor 5 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Metabotropic Glutamate Receptor 5 players cover Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bristol-Myers Squibb Company, and Eisai Co Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 5 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Metabotropic Glutamate Receptor 5 will have significant change from previous year. According to our (LP Information) latest study, the global Metabotropic Glutamate Receptor 5 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Metabotropic Glutamate Receptor 5 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Metabotropic Glutamate Receptor 5 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Metabotropic Glutamate Receptor 5 market, reaching US$ million by the year 2028. As for the Europe Metabotropic Glutamate Receptor 5 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Metabotropic Glutamate Receptor 5 players cover Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bristol-Myers Squibb Company, and Eisai Co Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 5 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Alloswitch-1
- BMS-952048
- BMS-955829
- Dipraglurant ER
- Others
- Major Depressive Disorder
- Alcohol Addiction
- Alzheimer's Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Addex Therapeutics Ltd
- Aevi Genomic Medicine Inc
- Bristol-Myers Squibb Company
- Eisai Co Ltd
- Eli Lilly and Company
- Heptares Therapeutics Ltd
- Johnson & Johnson
- Merz Pharma GmbH & Co KgaA
- Novartis AG
- Richter Gedeon Nyrt
- Sumitomo Dainippon Pharma Co Ltd
- Toray Industries Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Metabotropic Glutamate Receptor 5 by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 5 by Country/Region, 2017, 2022 & 2028
2.2 Metabotropic Glutamate Receptor 5 Segment by Type
2.2.1 Alloswitch-1
2.2.2 BMS-952048
2.2.3 BMS-955829
2.2.4 Dipraglurant ER
2.2.5 Others
2.3 Metabotropic Glutamate Receptor 5 Sales by Type
2.3.1 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
2.3.2 Global Metabotropic Glutamate Receptor 5 Revenue and Market Share by Type (2017-2022)
2.3.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Type (2017-2022)
2.4 Metabotropic Glutamate Receptor 5 Segment by Application
2.4.1 Major Depressive Disorder
2.4.2 Alcohol Addiction
2.4.3 Alzheimer's Disease
2.4.4 Others
2.5 Metabotropic Glutamate Receptor 5 Sales by Application
2.5.1 Global Metabotropic Glutamate Receptor 5 Sale Market Share by Application (2017-2022)
2.5.2 Global Metabotropic Glutamate Receptor 5 Revenue and Market Share by Application (2017-2022)
2.5.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Application (2017-2022)
3 GLOBAL METABOTROPIC GLUTAMATE RECEPTOR 5 BY COMPANY
3.1 Global Metabotropic Glutamate Receptor 5 Breakdown Data by Company
3.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Company (2020-2022)
3.1.2 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2020-2022)
3.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Company (2020-2022)
3.2.1 Global Metabotropic Glutamate Receptor 5 Revenue by Company (2020-2022)
3.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2020-2022)
3.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Company
3.4 Key Manufacturers Metabotropic Glutamate Receptor 5 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Metabotropic Glutamate Receptor 5 Product Location Distribution
3.4.2 Players Metabotropic Glutamate Receptor 5 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR 5 BY GEOGRAPHIC REGION
4.1 World Historic Metabotropic Glutamate Receptor 5 Market Size by Geographic Region (2017-2022)
4.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Geographic Region
4.2 World Historic Metabotropic Glutamate Receptor 5 Market Size by Country/Region (2017-2022)
4.2.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Country/Region (2017-2022)
4.2.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Country/Region
4.3 Americas Metabotropic Glutamate Receptor 5 Sales Growth
4.4 APAC Metabotropic Glutamate Receptor 5 Sales Growth
4.5 Europe Metabotropic Glutamate Receptor 5 Sales Growth
4.6 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Growth
5 AMERICAS
5.1 Americas Metabotropic Glutamate Receptor 5 Sales by Country
5.1.1 Americas Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022)
5.1.2 Americas Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022)
5.2 Americas Metabotropic Glutamate Receptor 5 Sales by Type
5.3 Americas Metabotropic Glutamate Receptor 5 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metabotropic Glutamate Receptor 5 Sales by Region
6.1.1 APAC Metabotropic Glutamate Receptor 5 Sales by Region (2017-2022)
6.1.2 APAC Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2022)
6.2 APAC Metabotropic Glutamate Receptor 5 Sales by Type
6.3 APAC Metabotropic Glutamate Receptor 5 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Metabotropic Glutamate Receptor 5 by Country
7.1.1 Europe Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022)
7.1.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022)
7.2 Europe Metabotropic Glutamate Receptor 5 Sales by Type
7.3 Europe Metabotropic Glutamate Receptor 5 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Metabotropic Glutamate Receptor 5 by Country
8.1.1 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022)
8.1.2 Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022)
8.2 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Type
8.3 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor
10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor
10.4 Industry Chain Structure of Metabotropic Glutamate Receptor
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Metabotropic Glutamate Receptor 5 Distributors
11.3 Metabotropic Glutamate Receptor 5 Customer
12 WORLD FORECAST REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR 5 BY GEOGRAPHIC REGION
12.1 Global Metabotropic Glutamate Receptor 5 Market Size Forecast by Region
12.1.1 Global Metabotropic Glutamate Receptor 5 Forecast by Region (2023-2028)
12.1.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Metabotropic Glutamate Receptor 5 Forecast by Type
12.7 Global Metabotropic Glutamate Receptor 5 Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Addex Therapeutics Ltd
13.1.1 Addex Therapeutics Ltd Company Information
13.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered
13.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Addex Therapeutics Ltd Main Business Overview
13.1.5 Addex Therapeutics Ltd Latest Developments
13.2 Aevi Genomic Medicine Inc
13.2.1 Aevi Genomic Medicine Inc Company Information
13.2.2 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Offered
13.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Aevi Genomic Medicine Inc Main Business Overview
13.2.5 Aevi Genomic Medicine Inc Latest Developments
13.3 Bristol-Myers Squibb Company
13.3.1 Bristol-Myers Squibb Company Company Information
13.3.2 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Offered
13.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bristol-Myers Squibb Company Main Business Overview
13.3.5 Bristol-Myers Squibb Company Latest Developments
13.4 Eisai Co Ltd
13.4.1 Eisai Co Ltd Company Information
13.4.2 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Offered
13.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eisai Co Ltd Main Business Overview
13.4.5 Eisai Co Ltd Latest Developments
13.5 Eli Lilly and Company
13.5.1 Eli Lilly and Company Company Information
13.5.2 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Offered
13.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Eli Lilly and Company Main Business Overview
13.5.5 Eli Lilly and Company Latest Developments
13.6 Heptares Therapeutics Ltd
13.6.1 Heptares Therapeutics Ltd Company Information
13.6.2 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered
13.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Heptares Therapeutics Ltd Main Business Overview
13.6.5 Heptares Therapeutics Ltd Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Offered
13.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Merz Pharma GmbH & Co KgaA
13.8.1 Merz Pharma GmbH & Co KgaA Company Information
13.8.2 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Offered
13.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merz Pharma GmbH & Co KgaA Main Business Overview
13.8.5 Merz Pharma GmbH & Co KgaA Latest Developments
13.9 Novartis AG
13.9.1 Novartis AG Company Information
13.9.2 Novartis AG Metabotropic Glutamate Receptor 5 Product Offered
13.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Novartis AG Main Business Overview
13.9.5 Novartis AG Latest Developments
13.10 Richter Gedeon Nyrt
13.10.1 Richter Gedeon Nyrt Company Information
13.10.2 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Offered
13.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Richter Gedeon Nyrt Main Business Overview
13.10.5 Richter Gedeon Nyrt Latest Developments
13.11 Sumitomo Dainippon Pharma Co Ltd
13.11.1 Sumitomo Dainippon Pharma Co Ltd Company Information
13.11.2 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Offered
13.11.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Sumitomo Dainippon Pharma Co Ltd Main Business Overview
13.11.5 Sumitomo Dainippon Pharma Co Ltd Latest Developments
13.12 Toray Industries Inc
13.12.1 Toray Industries Inc Company Information
13.12.2 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Offered
13.12.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Toray Industries Inc Main Business Overview
13.12.5 Toray Industries Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Metabotropic Glutamate Receptor 5 by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 5 by Country/Region, 2017, 2022 & 2028
2.2 Metabotropic Glutamate Receptor 5 Segment by Type
2.2.1 Alloswitch-1
2.2.2 BMS-952048
2.2.3 BMS-955829
2.2.4 Dipraglurant ER
2.2.5 Others
2.3 Metabotropic Glutamate Receptor 5 Sales by Type
2.3.1 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
2.3.2 Global Metabotropic Glutamate Receptor 5 Revenue and Market Share by Type (2017-2022)
2.3.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Type (2017-2022)
2.4 Metabotropic Glutamate Receptor 5 Segment by Application
2.4.1 Major Depressive Disorder
2.4.2 Alcohol Addiction
2.4.3 Alzheimer's Disease
2.4.4 Others
2.5 Metabotropic Glutamate Receptor 5 Sales by Application
2.5.1 Global Metabotropic Glutamate Receptor 5 Sale Market Share by Application (2017-2022)
2.5.2 Global Metabotropic Glutamate Receptor 5 Revenue and Market Share by Application (2017-2022)
2.5.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Application (2017-2022)
3 GLOBAL METABOTROPIC GLUTAMATE RECEPTOR 5 BY COMPANY
3.1 Global Metabotropic Glutamate Receptor 5 Breakdown Data by Company
3.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Company (2020-2022)
3.1.2 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2020-2022)
3.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Company (2020-2022)
3.2.1 Global Metabotropic Glutamate Receptor 5 Revenue by Company (2020-2022)
3.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2020-2022)
3.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Company
3.4 Key Manufacturers Metabotropic Glutamate Receptor 5 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Metabotropic Glutamate Receptor 5 Product Location Distribution
3.4.2 Players Metabotropic Glutamate Receptor 5 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR 5 BY GEOGRAPHIC REGION
4.1 World Historic Metabotropic Glutamate Receptor 5 Market Size by Geographic Region (2017-2022)
4.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Geographic Region
4.2 World Historic Metabotropic Glutamate Receptor 5 Market Size by Country/Region (2017-2022)
4.2.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Country/Region (2017-2022)
4.2.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Country/Region
4.3 Americas Metabotropic Glutamate Receptor 5 Sales Growth
4.4 APAC Metabotropic Glutamate Receptor 5 Sales Growth
4.5 Europe Metabotropic Glutamate Receptor 5 Sales Growth
4.6 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Growth
5 AMERICAS
5.1 Americas Metabotropic Glutamate Receptor 5 Sales by Country
5.1.1 Americas Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022)
5.1.2 Americas Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022)
5.2 Americas Metabotropic Glutamate Receptor 5 Sales by Type
5.3 Americas Metabotropic Glutamate Receptor 5 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metabotropic Glutamate Receptor 5 Sales by Region
6.1.1 APAC Metabotropic Glutamate Receptor 5 Sales by Region (2017-2022)
6.1.2 APAC Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2022)
6.2 APAC Metabotropic Glutamate Receptor 5 Sales by Type
6.3 APAC Metabotropic Glutamate Receptor 5 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Metabotropic Glutamate Receptor 5 by Country
7.1.1 Europe Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022)
7.1.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022)
7.2 Europe Metabotropic Glutamate Receptor 5 Sales by Type
7.3 Europe Metabotropic Glutamate Receptor 5 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Metabotropic Glutamate Receptor 5 by Country
8.1.1 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022)
8.1.2 Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022)
8.2 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Type
8.3 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor
10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor
10.4 Industry Chain Structure of Metabotropic Glutamate Receptor
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Metabotropic Glutamate Receptor 5 Distributors
11.3 Metabotropic Glutamate Receptor 5 Customer
12 WORLD FORECAST REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR 5 BY GEOGRAPHIC REGION
12.1 Global Metabotropic Glutamate Receptor 5 Market Size Forecast by Region
12.1.1 Global Metabotropic Glutamate Receptor 5 Forecast by Region (2023-2028)
12.1.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Metabotropic Glutamate Receptor 5 Forecast by Type
12.7 Global Metabotropic Glutamate Receptor 5 Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Addex Therapeutics Ltd
13.1.1 Addex Therapeutics Ltd Company Information
13.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered
13.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Addex Therapeutics Ltd Main Business Overview
13.1.5 Addex Therapeutics Ltd Latest Developments
13.2 Aevi Genomic Medicine Inc
13.2.1 Aevi Genomic Medicine Inc Company Information
13.2.2 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Offered
13.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Aevi Genomic Medicine Inc Main Business Overview
13.2.5 Aevi Genomic Medicine Inc Latest Developments
13.3 Bristol-Myers Squibb Company
13.3.1 Bristol-Myers Squibb Company Company Information
13.3.2 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Offered
13.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bristol-Myers Squibb Company Main Business Overview
13.3.5 Bristol-Myers Squibb Company Latest Developments
13.4 Eisai Co Ltd
13.4.1 Eisai Co Ltd Company Information
13.4.2 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Offered
13.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eisai Co Ltd Main Business Overview
13.4.5 Eisai Co Ltd Latest Developments
13.5 Eli Lilly and Company
13.5.1 Eli Lilly and Company Company Information
13.5.2 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Offered
13.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Eli Lilly and Company Main Business Overview
13.5.5 Eli Lilly and Company Latest Developments
13.6 Heptares Therapeutics Ltd
13.6.1 Heptares Therapeutics Ltd Company Information
13.6.2 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered
13.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Heptares Therapeutics Ltd Main Business Overview
13.6.5 Heptares Therapeutics Ltd Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Offered
13.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Merz Pharma GmbH & Co KgaA
13.8.1 Merz Pharma GmbH & Co KgaA Company Information
13.8.2 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Offered
13.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merz Pharma GmbH & Co KgaA Main Business Overview
13.8.5 Merz Pharma GmbH & Co KgaA Latest Developments
13.9 Novartis AG
13.9.1 Novartis AG Company Information
13.9.2 Novartis AG Metabotropic Glutamate Receptor 5 Product Offered
13.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Novartis AG Main Business Overview
13.9.5 Novartis AG Latest Developments
13.10 Richter Gedeon Nyrt
13.10.1 Richter Gedeon Nyrt Company Information
13.10.2 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Offered
13.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Richter Gedeon Nyrt Main Business Overview
13.10.5 Richter Gedeon Nyrt Latest Developments
13.11 Sumitomo Dainippon Pharma Co Ltd
13.11.1 Sumitomo Dainippon Pharma Co Ltd Company Information
13.11.2 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Offered
13.11.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Sumitomo Dainippon Pharma Co Ltd Main Business Overview
13.11.5 Sumitomo Dainippon Pharma Co Ltd Latest Developments
13.12 Toray Industries Inc
13.12.1 Toray Industries Inc Company Information
13.12.2 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Offered
13.12.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Toray Industries Inc Main Business Overview
13.12.5 Toray Industries Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Metabotropic Glutamate Receptor 5 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Metabotropic Glutamate Receptor 5 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Alloswitch-1
Table 4. Major Players of BMS-952048
Table 5. Major Players of BMS-955829
Table 6. Major Players of Dipraglurant ER
Table 7. Major Players of Others
Table 8. Global Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
Table 10. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2022) & ($ million)
Table 11. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2022)
Table 12. Global Metabotropic Glutamate Receptor 5 Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Table 15. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2022)
Table 16. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2017-2022)
Table 17. Global Metabotropic Glutamate Receptor 5 Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Metabotropic Glutamate Receptor 5 Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2020-2022)
Table 20. Global Metabotropic Glutamate Receptor 5 Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2020-2022)
Table 22. Global Metabotropic Glutamate Receptor 5 Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Metabotropic Glutamate Receptor 5 Producing Area Distribution and Sales Area
Table 24. Players Metabotropic Glutamate Receptor 5 Products Offered
Table 25. Metabotropic Glutamate Receptor 5 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Metabotropic Glutamate Receptor 5 Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Metabotropic Glutamate Receptor 5 Sales Market Share Geographic Region (2017-2022)
Table 30. Global Metabotropic Glutamate Receptor 5 Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Metabotropic Glutamate Receptor 5 Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Country/Region (2017-2022)
Table 34. Global Metabotropic Glutamate Receptor 5 Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2017-2022)
Table 38. Americas Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2017-2022)
Table 40. Americas Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
Table 42. Americas Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Table 44. APAC Metabotropic Glutamate Receptor 5 Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2017-2022)
Table 46. APAC Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2017-2022)
Table 48. APAC Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
Table 50. APAC Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Table 52. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2017-2022)
Table 54. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2017-2022)
Table 56. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
Table 58. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor 5
Table 69. Key Market Challenges & Risks of Metabotropic Glutamate Receptor 5
Table 70. Key Industry Trends of Metabotropic Glutamate Receptor 5
Table 71. Metabotropic Glutamate Receptor 5 Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Metabotropic Glutamate Receptor 5 Distributors List
Table 74. Metabotropic Glutamate Receptor 5 Customer List
Table 75. Global Metabotropic Glutamate Receptor 5 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Metabotropic Glutamate Receptor 5 Sales Market Forecast by Region
Table 77. Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Metabotropic Glutamate Receptor 5 Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Metabotropic Glutamate Receptor 5 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Metabotropic Glutamate Receptor 5 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Metabotropic Glutamate Receptor 5 Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Metabotropic Glutamate Receptor 5 Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Metabotropic Glutamate Receptor 5 Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Metabotropic Glutamate Receptor 5 Revenue Market Share Forecast by Application (2023-2028)
Table 95. Addex Therapeutics Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 96. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered
Table 97. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Addex Therapeutics Ltd Main Business
Table 99. Addex Therapeutics Ltd Latest Developments
Table 100. Aevi Genomic Medicine Inc Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 101. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Offered
Table 102. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Aevi Genomic Medicine Inc Main Business
Table 104. Aevi Genomic Medicine Inc Latest Developments
Table 105. Bristol-Myers Squibb Company Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 106. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Offered
Table 107. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Bristol-Myers Squibb Company Main Business
Table 109. Bristol-Myers Squibb Company Latest Developments
Table 110. Eisai Co Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 111. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Offered
Table 112. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Eisai Co Ltd Main Business
Table 114. Eisai Co Ltd Latest Developments
Table 115. Eli Lilly and Company Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 116. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Offered
Table 117. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Eli Lilly and Company Main Business
Table 119. Eli Lilly and Company Latest Developments
Table 120. Heptares Therapeutics Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 121. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered
Table 122. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Heptares Therapeutics Ltd Main Business
Table 124. Heptares Therapeutics Ltd Latest Developments
Table 125. Johnson & Johnson Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 126. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Offered
Table 127. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Johnson & Johnson Main Business
Table 129. Johnson & Johnson Latest Developments
Table 130. Merz Pharma GmbH & Co KgaA Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 131. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Offered
Table 132. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Merz Pharma GmbH & Co KgaA Main Business
Table 134. Merz Pharma GmbH & Co KgaA Latest Developments
Table 135. Novartis AG Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 136. Novartis AG Metabotropic Glutamate Receptor 5 Product Offered
Table 137. Novartis AG Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Novartis AG Main Business
Table 139. Novartis AG Latest Developments
Table 140. Richter Gedeon Nyrt Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 141. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Offered
Table 142. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. Richter Gedeon Nyrt Main Business
Table 144. Richter Gedeon Nyrt Latest Developments
Table 145. Sumitomo Dainippon Pharma Co Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 146. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Offered
Table 147. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 148. Sumitomo Dainippon Pharma Co Ltd Main Business
Table 149. Sumitomo Dainippon Pharma Co Ltd Latest Developments
Table 150. Toray Industries Inc Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 151. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Offered
Table 152. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 153. Toray Industries Inc Main Business
Table 154. Toray Industries Inc Latest Developments
Table 1. Metabotropic Glutamate Receptor 5 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Metabotropic Glutamate Receptor 5 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Alloswitch-1
Table 4. Major Players of BMS-952048
Table 5. Major Players of BMS-955829
Table 6. Major Players of Dipraglurant ER
Table 7. Major Players of Others
Table 8. Global Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
Table 10. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2022) & ($ million)
Table 11. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2022)
Table 12. Global Metabotropic Glutamate Receptor 5 Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Table 15. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2022)
Table 16. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2017-2022)
Table 17. Global Metabotropic Glutamate Receptor 5 Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Metabotropic Glutamate Receptor 5 Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2020-2022)
Table 20. Global Metabotropic Glutamate Receptor 5 Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2020-2022)
Table 22. Global Metabotropic Glutamate Receptor 5 Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Metabotropic Glutamate Receptor 5 Producing Area Distribution and Sales Area
Table 24. Players Metabotropic Glutamate Receptor 5 Products Offered
Table 25. Metabotropic Glutamate Receptor 5 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Metabotropic Glutamate Receptor 5 Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Metabotropic Glutamate Receptor 5 Sales Market Share Geographic Region (2017-2022)
Table 30. Global Metabotropic Glutamate Receptor 5 Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Metabotropic Glutamate Receptor 5 Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Country/Region (2017-2022)
Table 34. Global Metabotropic Glutamate Receptor 5 Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2017-2022)
Table 38. Americas Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2017-2022)
Table 40. Americas Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
Table 42. Americas Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Table 44. APAC Metabotropic Glutamate Receptor 5 Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2017-2022)
Table 46. APAC Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2017-2022)
Table 48. APAC Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
Table 50. APAC Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Table 52. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2017-2022)
Table 54. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2017-2022)
Table 56. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
Table 58. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor 5
Table 69. Key Market Challenges & Risks of Metabotropic Glutamate Receptor 5
Table 70. Key Industry Trends of Metabotropic Glutamate Receptor 5
Table 71. Metabotropic Glutamate Receptor 5 Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Metabotropic Glutamate Receptor 5 Distributors List
Table 74. Metabotropic Glutamate Receptor 5 Customer List
Table 75. Global Metabotropic Glutamate Receptor 5 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Metabotropic Glutamate Receptor 5 Sales Market Forecast by Region
Table 77. Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Metabotropic Glutamate Receptor 5 Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Metabotropic Glutamate Receptor 5 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Metabotropic Glutamate Receptor 5 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Metabotropic Glutamate Receptor 5 Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Metabotropic Glutamate Receptor 5 Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Metabotropic Glutamate Receptor 5 Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Metabotropic Glutamate Receptor 5 Revenue Market Share Forecast by Application (2023-2028)
Table 95. Addex Therapeutics Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 96. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered
Table 97. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Addex Therapeutics Ltd Main Business
Table 99. Addex Therapeutics Ltd Latest Developments
Table 100. Aevi Genomic Medicine Inc Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 101. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Offered
Table 102. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Aevi Genomic Medicine Inc Main Business
Table 104. Aevi Genomic Medicine Inc Latest Developments
Table 105. Bristol-Myers Squibb Company Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 106. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Offered
Table 107. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Bristol-Myers Squibb Company Main Business
Table 109. Bristol-Myers Squibb Company Latest Developments
Table 110. Eisai Co Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 111. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Offered
Table 112. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Eisai Co Ltd Main Business
Table 114. Eisai Co Ltd Latest Developments
Table 115. Eli Lilly and Company Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 116. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Offered
Table 117. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Eli Lilly and Company Main Business
Table 119. Eli Lilly and Company Latest Developments
Table 120. Heptares Therapeutics Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 121. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered
Table 122. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Heptares Therapeutics Ltd Main Business
Table 124. Heptares Therapeutics Ltd Latest Developments
Table 125. Johnson & Johnson Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 126. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Offered
Table 127. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Johnson & Johnson Main Business
Table 129. Johnson & Johnson Latest Developments
Table 130. Merz Pharma GmbH & Co KgaA Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 131. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Offered
Table 132. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Merz Pharma GmbH & Co KgaA Main Business
Table 134. Merz Pharma GmbH & Co KgaA Latest Developments
Table 135. Novartis AG Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 136. Novartis AG Metabotropic Glutamate Receptor 5 Product Offered
Table 137. Novartis AG Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Novartis AG Main Business
Table 139. Novartis AG Latest Developments
Table 140. Richter Gedeon Nyrt Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 141. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Offered
Table 142. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. Richter Gedeon Nyrt Main Business
Table 144. Richter Gedeon Nyrt Latest Developments
Table 145. Sumitomo Dainippon Pharma Co Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 146. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Offered
Table 147. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 148. Sumitomo Dainippon Pharma Co Ltd Main Business
Table 149. Sumitomo Dainippon Pharma Co Ltd Latest Developments
Table 150. Toray Industries Inc Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors
Table 151. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Offered
Table 152. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 153. Toray Industries Inc Main Business
Table 154. Toray Industries Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Metabotropic Glutamate Receptor 5
Figure 2. Metabotropic Glutamate Receptor 5 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Metabotropic Glutamate Receptor 5 Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Metabotropic Glutamate Receptor 5 Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Metabotropic Glutamate Receptor 5 Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Alloswitch-1
Figure 10. Product Picture of BMS-952048
Figure 11. Product Picture of BMS-955829
Figure 12. Product Picture of Dipraglurant ER
Figure 13. Product Picture of Others
Figure 14. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2021
Figure 15. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2022)
Figure 16. Metabotropic Glutamate Receptor 5 Consumed in Major Depressive Disorder
Figure 17. Global Metabotropic Glutamate Receptor 5 Market: Major Depressive Disorder (2017-2022) & (K Pcs)
Figure 18. Metabotropic Glutamate Receptor 5 Consumed in Alcohol Addiction
Figure 19. Global Metabotropic Glutamate Receptor 5 Market: Alcohol Addiction (2017-2022) & (K Pcs)
Figure 20. Metabotropic Glutamate Receptor 5 Consumed in Alzheimer's Disease
Figure 21. Global Metabotropic Glutamate Receptor 5 Market: Alzheimer's Disease (2017-2022) & (K Pcs)
Figure 22. Metabotropic Glutamate Receptor 5 Consumed in Others
Figure 23. Global Metabotropic Glutamate Receptor 5 Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Figure 25. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application in 2021
Figure 26. Metabotropic Glutamate Receptor 5 Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company in 2021
Figure 28. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Geographic Region in 2021
Figure 30. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2017-2022)
Figure 31. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Country/Region in 2021
Figure 32. Americas Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)
Figure 33. Americas Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)
Figure 34. APAC Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)
Figure 35. APAC Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)
Figure 36. Europe Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)
Figure 37. Europe Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)
Figure 40. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2021
Figure 41. Americas Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2021
Figure 42. United States Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Region in 2021
Figure 47. APAC Metabotropic Glutamate Receptor 5 Revenue Market Share by Regions in 2021
Figure 48. China Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2021
Figure 55. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2021
Figure 56. Germany Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2021
Figure 63. Egypt Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 5 in 2021
Figure 69. Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5
Figure 70. Industry Chain Structure of Metabotropic Glutamate Receptor 5
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 1. Picture of Metabotropic Glutamate Receptor 5
Figure 2. Metabotropic Glutamate Receptor 5 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Metabotropic Glutamate Receptor 5 Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Metabotropic Glutamate Receptor 5 Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Metabotropic Glutamate Receptor 5 Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Alloswitch-1
Figure 10. Product Picture of BMS-952048
Figure 11. Product Picture of BMS-955829
Figure 12. Product Picture of Dipraglurant ER
Figure 13. Product Picture of Others
Figure 14. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2021
Figure 15. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2022)
Figure 16. Metabotropic Glutamate Receptor 5 Consumed in Major Depressive Disorder
Figure 17. Global Metabotropic Glutamate Receptor 5 Market: Major Depressive Disorder (2017-2022) & (K Pcs)
Figure 18. Metabotropic Glutamate Receptor 5 Consumed in Alcohol Addiction
Figure 19. Global Metabotropic Glutamate Receptor 5 Market: Alcohol Addiction (2017-2022) & (K Pcs)
Figure 20. Metabotropic Glutamate Receptor 5 Consumed in Alzheimer's Disease
Figure 21. Global Metabotropic Glutamate Receptor 5 Market: Alzheimer's Disease (2017-2022) & (K Pcs)
Figure 22. Metabotropic Glutamate Receptor 5 Consumed in Others
Figure 23. Global Metabotropic Glutamate Receptor 5 Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)
Figure 25. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application in 2021
Figure 26. Metabotropic Glutamate Receptor 5 Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company in 2021
Figure 28. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Geographic Region in 2021
Figure 30. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2017-2022)
Figure 31. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Country/Region in 2021
Figure 32. Americas Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)
Figure 33. Americas Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)
Figure 34. APAC Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)
Figure 35. APAC Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)
Figure 36. Europe Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)
Figure 37. Europe Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)
Figure 40. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2021
Figure 41. Americas Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2021
Figure 42. United States Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Region in 2021
Figure 47. APAC Metabotropic Glutamate Receptor 5 Revenue Market Share by Regions in 2021
Figure 48. China Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2021
Figure 55. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2021
Figure 56. Germany Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2021
Figure 63. Egypt Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 5 in 2021
Figure 69. Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5
Figure 70. Industry Chain Structure of Metabotropic Glutamate Receptor 5
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
